Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Diabetes & Metabolic Disorders
Erschienen in: Journal of Diabetes & Metabolic Disorders 1/2021

05.04.2021 | COVID-19 | Review article Zur Zeit gratis

Nutritional management of diabetes mellitus during the pandemic of COVID-19: a comprehensive narrative review

verfasst von: Sepideh Mahluji, Mahsa Jalili, Alireza Ostadrahimi, Jamal Hallajzadeh, Vahideh Ebrahimzadeh-Attari, Maryam Saghafi-Asl

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Objectives

According to the recent epidemiological studies, patients with diabetes mellitus (DM) may be at higher risk of hospitalization due to COVID-19. Regarding the important role of nutrition on the immunity, the present review article aimed to outline nutritional support of DM during the outbreak of COVID-19 with a mechanistic insight.

Methods

Searches were performed in PubMed/MEDLINE, ScienceDirect, Scopus, and Google Scholar databases from 2000 until December 2020 using the following keywords. All relevant clinical and experimental studies published in English were included.

Results

Evidences revealed that hyperglycemia is a significant predictor of some viral infections including COVID-19 which can exacerbate the complications of DM. According to the literature review, adequate intake of dietary protein, fiber, essential fatty acids and some micronutrients especially vitamins D, C, B12, folate, zinc and selenium has beneficial effects on the prevention and treatment of COVID-19 in diabetic patients through modulation of innate and adaptive immune responses or direct effects on virus enzymes or the rate of cell entrance.

Conclusions

It is well understood that malnutrition may increase susceptibility to viral infections and disease progression. Therefore, considering nutritional status of diabetic patients and reasonable supplementation of the above mentioned nutrients can ameliorate the symptoms of COVID-19 in DM. However, further well-designed clinical trials are needed to determine their therapeutic dose.
Literatur
1.
Palacios Cruz M, Santos E, Velázquez Cervantes MA, León Juárez M. COVID-19, a worldwide public health emergency. Rev Clin Esp. 2020;S0014-2565(20):30092–8.
2.
3.
Ghelichi Ghojogh M, Allah Kalteh E, Fararooei M. Coronavirus disease 2019; epidemiology and recommendations. J Prev Epidemiol. 2020;5(1):e01.
4.
Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020;395(10223):514–23.
5.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.
6.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.PubMedPubMedCentral
7.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.PubMedPubMedCentral
8.
Chen L, Hao G. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease. Cardiovasc Res. 2020;0:1–5.
9.
Dadashzadeh N, Farshid S, Valizadeh R, Nanbakhsh M, Rahimi MM. Acute respiratory distress syndrome in COVID-19. Immunopathol Persa. 2020;6(2):e16.
10.
Wang LS, Wang YR, Ye DW, Liu Q. A review of the 2019 novel coronavirus (COVID-19) based on current evidence. Int J Antimicrob Agents. 2020;55(6):105948.PubMedPubMedCentral
11.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.PubMedPubMedCentral
12.
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–4.PubMedPubMedCentral
13.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.PubMed
14.
Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J. Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol. 2016;4(2):148–58.PubMed
15.
Faghir-Gangi M, Moameri H, Abdolmohamadi N, Nematollahi SH. The prevalence of type 2 diabetes in patients with COVID-19: a systematic review and meta-analysis. Via Medica. 2020;9(5):271–8.
16.
Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterization Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.PubMedPubMedCentral
17.
Riddle MC, Buse JB, Franks PW, Knowler WC, Ratner RE, Selvin E, et al. COVID-19 in people with diabetes: urgently needed lessons from early reports. Diabetes Care. 2020;43(7):1378–81.PubMedPubMedCentral
18.
Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;S2213-8587(20):30272–2.
19.
Fadini G, Morieri M, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS–CoV–2. J Endocrinol Invest. 2020;43(6):867–9.PubMedPubMedCentral
20.
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–9.PubMedPubMedCentral
21.
Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63(8):1500–15.
22.
Orioli L, Hermans MP, Thissen JP, Maiter D, Vandeleene B, Yombi JC. COVID-19 in diabetic patients: Related risks and specifics of management. Ann Endocrinol (Paris). 2020;81(2–3):101–9.
23.
Knapp S. Diabetes and infection: is there a link? – A mini-review. Gerontology. 2013;59(2):99–104.PubMed
24.
Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Canadian J Cardiol. 2018;34(5):575–84.
25.
Ritz BW, Gardner EM. Malnutrition and energy restriction differentially affect viral immunity. J Nutr. 2006;136(5):1141–4.PubMed
26.
Soares MP, Teixeira L, Moita LF. Disease tolerance and immunity in host protection against infection. Nat Rev Immunol. 2017;17(2):83.PubMed
27.
Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis. 2006;6(7):438–46.PubMed
28.
Solomons NW. Malnutrition and infection: an update. Br J Nutr. 2007;98(Suppl 1(S1):5–10.
29.
Beck MA, Handy J, Levander OA. Host nutritional status: the neglected virulence factor. Trends Microbiol. 2004;12(9):417–23.PubMedPubMedCentral
30.
Acosta-Elias J, Espinosa-Tanguma R. The folate concentration and/or folic acid metabolites in plasma as factor for COVID-19 infection. Front Pharmacol. 2020;11:1062.PubMedPubMedCentral
31.
32.
Razdan K, Singh K, Singh D. Vitamin D, Levels. and COVID-19 Susceptibility: Is there any Correlation? Med Drug Discov. 2020;7:100051.PubMedPubMedCentral
33.
34.
Hiedra R, Bryan Lo K, Elbashabsheh M, Gul F, Wright RM, Albano J, et al. The use of IV vitamin C for patients with COVID-19: a single center observational study. Expert Rev Anti Infect Ther. 2020;5:100028.
35.
Zhang J, Taylor EW, Bennett K, Saad R, Rayman MP. Association between regional selenium status and reported outcome of COVID-19 cases in China. Am J Clin Nutr. 2020;111(6):1297–99.PubMed
36.
Moghaddam A, Heller RA, Sun Q, Seelig J, Cherkezov A, Seibert L, et al. Selenium deficiency is associated with mortality risk from COVID-19. Nutrients. 2020;12:2098.
37.
Mossink JP. Zinc as nutritional intervention and prevention measure for COVID–19 disease. BMJ Nutr Prev Health. 2020;3(1):1–7.
38.
Velthuis AJW, van den Worm SHE, Sims AC, Baric RS, Snijder EJ, van Hemer MJ. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6(11):e1001176.
39.
Schoen K, Horvat N, Guerreiro NFC, de Castro I, de Giassi KS. Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC Infect Dis. 2019;19:964.
40.
Yang JK, Feng Y, Yuan MY, Yuan SY, Fu HJ, Wu BY, et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006;23(6):623–8.PubMed
41.
Banik GR, Alqahtani AS, Booy R, Rashid H. Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia. Virol Sin. 2016;31(1):81–4.PubMedPubMedCentral
42.
Wang A, Zhao W, Xu Z, Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract. 2020;162:108118.PubMedPubMedCentral
43.
Varanasi SK, Donohoe D, Jaggi U, Rouse BT. Manipulating glucose metabolism during different stages of viral pathogenesis can have either detrimental or beneficial effects. J Immunol. 2017;199(5):1748–61.PubMed
44.
Wang A, Huen SC, Luan HH, Yu S, Zhang C, Gallezot J-D, et al. Opposing effects of fasting metabolism on tissue tolerance in bacterial and viral inflammation. Cell. 2016;166(6):1512–25. e12.PubMedPubMedCentral
45.
O’Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553–65.PubMedPubMedCentral
46.
Stachowska E, Folwarski M, Jamioł-Milc D, Maciejewska D, Skonieczna-Żydecka K. Nutritional support in coronavirus 2019 disease. Medicina. 2020;56(6):289.PubMedCentral
47.
Patel JJ, Martindale RG, McClave SA. Relevant nutrition therapy in COVID-19 and the constraints on its delivery by a unique disease process. Nutr Clin Pract. 2020;35(5):792–9.PubMed
48.
49.
Diabetes (India). National Diabetes Obesity and Cholesterol Foundation (NDOC), and Nutrition Expert Group, India. Balanced nutrition is needed. In: Times of COVID19 epidemic in India: A call for action for all nutritionists and physicians. Diabetes & Metabolic Syndrome: Clinical Research & Reviews; 2020. pp 1747–50.
50.
Collins PF, Stratton RJ, Elia M. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1385–95.PubMed
51.
Chatraw JH, Wherry EJ, Ahmed R, Kapasi ZF. Diminished primary CD8 T cell response to viral infection during protein energy malnutrition in mice is due to changes in microenvironment and low numbers of viral-specific CD8 T cell precursors. J Nutr. 2008;138(4):806–12.PubMed
52.
Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013;97(3):505–16.PubMed
53.
Taylor AK, Cao W, Vora KP, Cruz JDL, Shieh W-J, Zaki SR, et al. Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice. J Infect Dis. 2013;207(3):501–10.PubMed
54.
Hill K, Vogiatzis I, Burtin C. The importance of components of pulmonary rehabilitation, other than exercise training, in COPD. Eur Respir Rev. 2013;22(129):405–13.PubMed
55.
Khan SH, Karnik AM. Medical nutrition therapy for pulmonary disease. In: Kathleen L, Mahan JLR, editors. Krause’s Food & the Nutrition Care Process. Missouri: Elsevier; 2016. p. 681–697.
56.
Thibault R, Seguin P, Tamion F, Pichard C, Singer P. Nutrition of the COVID-19 patient in the intensive care unit (ICU): a practical guidance. Crit Care. 2020;24(1):447.PubMedPubMedCentral
57.
Kesteloot H. Epidemiology: past, present and future. Verh K Acad Geneeskd Belg. 2004;66(5–6):384–405.PubMed
58.
Das UN. Polyunsaturated fatty acids and sepsis. Nutrition. 2019;65:39–43.PubMed
59.
Husson M-O, Ley D, Portal C, Gottrand M, Hueso T, Desseyn J-L, et al. Modulation of host defence against bacterial and viral infections by omega-3 polyunsaturated fatty acids. J Infect. 2016;73(6):523–35.PubMed
60.
Rutting S, Zakarya R, Bozier J, Xenaki D, Horvat JC, Wood LG, et al. Dietary fatty acids amplify inflammatory responses to infection through p38 MAPK signaling. Am J Respir Cell Mol Biol. 2019;60(5):554–68.PubMed
61.
Schwerbrock NM, Karlsson EA, Shi Q, Sheridan PA, Beck MA. Fish oil-fed mice have impaired resistance to influenza infection. J Nutr. 2009;139(8):1588–94.PubMed
62.
Rutting S, Horvat J, Wood L, Hansbro P, Oliver B. The effect of dietary fatty acids on respiratory infection in human lung cells. Eur Respir J. 2018;52:PA4983.
63.
Kang KW, Kim S, Cho Y-B, Ryu SR, Seo Y-J, Lee S-M. Endogenous n-3 polyunsaturated fatty acids are beneficial to dampen CD8 + T cell-mediated inflammatory response upon the viral infection in mice. Int J Mol Sci. 2019;20(18):4510.PubMedCentral
64.
Goncalves-Mendes N, Talvas J, Duale C, Guttmann A, Corbin V, Marceau G, et al. Impact of vitamin D supplementation on influenza vaccine response and immune functions in deficient elderly persons: a randomized placebo-controlled trial. Front Immunol. 2019;10:65.PubMedPubMedCentral
65.
Natto ZS, Yaghmoor W, Alshaeri HK, Van Dyke TE. Omega-3 fatty acids effects on inflammatory biomarkers and lipid profiles among diabetic and cardiovascular disease patients: a systematic review and meta-analysis. Sci Rep. 2019;9(1):18867.PubMedPubMedCentral
66.
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.PubMedPubMedCentral
67.
Onishi JC, Häggblom MM, Shapses SA. Can dietary fatty acids affect the COVID-19 infection outcome in vulnerable populations? mBio. 2020;11(4):e01723-20.
68.
Butler MJ, Barrientos RM. The impact of nutrition on COVID-19 susceptibility and long-term consequences. Brain Behav Immun. 2020;87:53–4.PubMedPubMedCentral
69.
Dushianthan A, Cusack R, Burgess VA, Grocott MP, Calder P. Immunonutrition for adults with ARDS: results from a cochrane systematic review and meta-analysis. Respir Care. 2020;65(1):99–110.PubMed
70.
Langlois PL, D’Aragon F, Hardy G, Manzanares W. Omega-3 polyunsaturated fatty acids in critically ill patients with acute respiratory distress syndrome: A systematic review and meta-analysis. Nutrition. 2019;61:84–92.PubMed
71.
Turner KL, Moore FA, Martindale R. Nutrition support for the acute lung injury/adult respiratory distress syndrome patient: a review. Nutr Clin Pract. 2011;26(1):14–25.PubMed
72.
Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr. 2007;98:29–35.
73.
Saeed F, Nadeem M, Ahmed RS, Tahir Nadeem M, Arshad MS, Ullah A. Studying the impact of nutritional immunology underlying the modulation of immune responses by nutritional compounds – a review. Food Agric Immunol. 2016;27(2):205–29.
74.
Bunout D, Barrera G, Hirsch S, Gattas V, de la Maza MP, Haschke F, et al. Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. J Parenter Enteral Nutr. 2004;28(5):348–54.
75.
Smith AD. Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12. Am J Clin Nutr. 2007;85:3–5.PubMed
76.
Duthie SJ, Horgan G, De Roos B, Rucklidge G, Reid M, Duncan G, et al. Blood folate status and expression of proteins involved in immune function, inflammation, and coagulation: biochemical and proteomic changes in the plasma of humans in response to long-term synthetic folic acid supplementation. J Proteome Res. 2010;9(4):1941–50.PubMed
77.
Al-Maskari MY, Waly MI, Ali A, Al-Shuaibi YS, Ouhtit A. Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes. Nutrition. 2012;28(7–8):e23–6.PubMed
78.
Erkurt MA, Aydogdu I, Dikilitaş M, Kuku I, Kaya E, Bayraktar N, et al. Effects of cyanocobalamin on immunity in patients with pernicious anemia. Med Princ Pract. 2008;17:131–5.PubMed
79.
Kim J, Woo Ahn C, Fang S, Lee H, Suk Park J. Association between metformin dose and vitamin B12 deficiency in patients with type 2 diabetes. Medicine. 2019;98(46):e17918.PubMedPubMedCentral
80.
Wakeman M, Archer T. Metformin and micronutrient status in type 2 diabetes: does polypharmacy involving acid-suppressing medications affect vitamin B12 levels? Diabetes Metab Syndr Obes. 2020;13:2093–108.PubMedPubMedCentral
81.
Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, et al. Long-term metformin use and vitamin B12 Deficiency in the diabetes prevention program outcomes study. J Clin Endocrinol Metab. 2016;101(4):1754–61.PubMedPubMedCentral
82.
Jovic TH, Ali SR, Ibrahim N, Jessop ZM, Tarassoli SP, Dobbs TD, et al. Could vitamins help in the fight against COVID-19? Nutrients. 2020;12(9):E2550.PubMed
83.
Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, et al. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci. 2020;250:117583.PubMedPubMedCentral
84.
Yanagihara M, Nakamura M, Usui A, Nishida S, Ito E, Okawa M, et al. The melatonin receptor agonist is effective for free-running type circadian rhythm sleep disorder: case report on two sighted patients. Tohoku J Exp Med. 2014;234(2):123–8.PubMed
85.
dos Santos LMJ. Can vitamin B12 be an adjuvant to COVID-19 treatment? GSC Biol Pharm Sci. 2020;11(03):001–5.
86.
Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176:1872–90.
87.
Wu C, Zheng M, Yang Y, Gu X, Yang K, Li M, et al. Furin, a potential therapeutic target for covid-19. iScience. 2020;23(10):101642.
88.
89.
Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012;33(3):456–92.PubMedPubMedCentral
90.
Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol. 2004;89–90:121–5.PubMed
91.
Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab. 2001;86(2):888–94.PubMed
92.
Gysemans CA, Cardozo AK, Callewaert H, Giulietti A, Hulshagen L, Bouillon R, et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrin. 2005;146:1956–64.
93.
Park S, Kim DS, Kang S. Vitamin D deficiency impairs glucose-stimulated insulin secretion and increases insulin resistance by reducing PPAR-gamma expression in nonobese Type 2 diabetic rats. J Nutr Biochem. 2016;27:257–65.PubMed
94.
Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X. 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev. 2008;24:459–64.PubMed
95.
Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7(6):4240–70.PubMedPubMedCentral
96.
Zisi D, Challa A, Makis A. The association between vitamin D status and infectious diseases of the respiratory system in infancy and childhood. Hormones (Athens) 2019;18(4):353–63.
97.
Teymoori-Rad M, Shokri F, Salimi V, Marashi SM. The interplay between vitamin D and viral infections. Rev Med Virol. 2019;29(2):e2032.PubMed
98.
Zdrenghea MT, Makrinioti H, Bagacean C, Bush A, Johnston SL, Stanciu LA. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. 2017;27(1):e1909.
99.
Lee MD, Lin CH, Lei WT, Chang HY, Lee HC, Yeung CY, et al. Does vitamin D deficiency affect the immunogenic responses to influenza vaccination? A systematic review and meta-analysis. Nutrients. 2018;10(4):409.PubMedCentral
100.
Kohlmeier M. Avoidance of vitamin D deficiency to slow the COVID-19 pandemic. BMJ Nutr Prev Health. 2020;3(1):1–7.
101.
Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988.PubMedCentral
102.
Nurshad A. Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health. 2020;1390:8.
103.
Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482–96.PubMed
104.
PanareseA SE. Covid-19, and vitamin D. Aliment Pharmacol Ther. 2020;51(10):993–5.
105.
Ebadi M. Montano-Loza AJ. Perspective: improving vitamin D status in the management of COVID-19. Eur J Clin Nutr. 2020;74:856–9.PubMedPubMedCentral
106.
Merzon E, Tworowski D, Gorohovski A, Vinker Sh, Cohen AG, Green I, et al. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population based study. FEBS J. 2020;287(17):3693–02.PubMed
107.
Ginde AA, Blatchford P, Breese K, Zarrabi L, Linnebur S, Wallace J, et al. High-dose monthly vitamin D for prevention of acute respiratory infection in older long-term care residents: a randomized clinical trial. J Am Geriatr Soc. 2017;65(3):496–503.PubMed
108.
109.
Castro SM, Guerrero-Plata A, Suarez-Real G, Adegboyega PA, Colasurdo GN, Khan AM, et al. Antioxidant treatment ameliorates respiratory syncytial virus–induced disease and lung inflammation. Am J Respir Crit. 2006;174(12):1361–9.
110.
Hemilä H, Chalker E. Vitamin C can shorten the length of stay in the ICU: a meta analysis. Nutrients. 2019;11:708.PubMedCentral
111.
Gonzalez M, Berdiel M, Duconge J, Levy Th, Alfaro I, Morales-Borges R, et al. High dose vitamin C and influenza: a case report. J Orthomol Med. 2018;33:1–3.
112.
Ran L, Zhao W, Wang J, Wang H, Zhao Y, Tseng Y, et al. Extra dose of vitamin C based on a daily supplementation shortens the common cold: A meta-analysis of 9 randomized controlled trials. Biomed Res Int. 2018;1–12.
113.
Zhang J, Wang X, Vikash V, Ye Q, Wu D, Liu Y, et al. ROS and ROS-mediated cellular signaling. Oxid Med Cell Long. 2016;4350965:1–18.
114.
Praveen D, Puvvada RC, Aanandhi VA. Association of vitamin C status in diabetes mellitus: prevalence and predictors of vitamin C deficiency. Future J Pharm Sci. 2020;6:30.
115.
Das UN. Vitamin C for type 2 diabetes mellitus and hypertension. Arch Med Res. 2019;50(2):11–4.
116.
Varma V, Varma M, Dey Sarkar P, Varma A, Vyas S, Kulkarni R. Correlation of vitamin C with HbA1c and oxidative stress in diabetes mellitus with or without nephropathy. Natl J Med Res. 2014;4(2):151–5.
117.
Cheng R. Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)? Med Drug Discov. 2020;5:100028.PubMedPubMedCentral
118.
Rayman MP. Selenium and human health. Lancet. 2012;379:1256–68.PubMed
119.
Ng MP, Lee JC, Loke WM, Yeo LL, Quek AM, Lim EC, et al. Does influenza A infection increase oxidative damage? Antioxid Redox Signal. 2014;21(7):1025–31.PubMed
120.
Erkekoğlu P, Aşçı A, Ceyhan M, Kızılgün M, Schweizer U, Ataş C, et al. Selenium levels, selenoenzyme activities and oxidant/antioxidant parameters in H1N1-infected children. Turk J Pediatr. 2013;55(3):271–82
121.
Wei J, Zeng Ch, Gong Q, Yang H, Li X, Lei G, Yang T. The association between dietary selenium intake and diabetes: a cross-sectional study among middle-aged and older adults. Nutr J. 2015;14:18.PubMedPubMedCentral
122.
Kljai K, Runje R. Selenium and glycogen levels in diabetic patients. Biol Trace Elem Res. 2001;83:223–9.PubMed
123.
Hiffler L, Rakotoambinina B. Selenium and RNA virus interactions: Potential implications for SARS-CoV-2 infection (COVID-19). Front Nutr. 2020;7:164.
124.
Jinsong Zhang J, Taylor E, Bennett K, Saad R, Rayman M. Selenium supplementation in the prevention of coronavirus infections (COVID-19). Med Hypotheses. 2020;143:109878.
125.
Maares M, Haase H. Zinc and immunity: An essential interrelation. Arch Biochem Biophys. 2016;611:58–65.PubMed
126.
Clímaco Cruz KJ, Oliveira A, Marreiro D. Antioxidant role of zinc in diabetes mellitus. World J Diabetes. 2015;15(6(2):333–7.
127.
Miao X, Sun W, Fu Y, Miao L, Cai L. Zinc homeostasis in the metabolic syndrome and diabetes. Front Med. 2013;7:31–52.PubMed
128.
Capdor J, Foster M, Petocz P, Samman S. Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans. J Trace Elem Med Biol. 2013;27:137–42.PubMed
129.
Poliana Guiomar de Almeida Brasiel. The key role of zinc in elderly immunity: A possible approach in the COVID-19 crisis. Clin Nutr. 2020;38:65–6.
130.
131.
Carocho M, Ferreira IC. A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chem Toxicol. 2013;51:15–25.PubMed
132.
Han YS, Chang GG, Juo CG, Lee HJ, Yeh SH, Hsu JT, et al. Papain-Like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition. Biochemistry. 2005;44:10349–59.PubMed
133.
Shittu MO, Afolami OI. Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials. Infez Med. 2020;28:192–7.PubMed
134.
Speth R, Carrera E, Jean–Baptiste M, Joachim A, Linares A. Concentration–dependent effects of zinc on angiotensin–converting enzyme–2 activity. FASEB J. 2014;28(S1):1067.4.
135.
Arentz S, Hunter J, Yang G, Beardsley J, Myers SP, Mertz D, et al. Zinc for the prevention and treatment of SARS-CoV-2 and other acute viral respiratory infections: a rapid review. Adv Integr Med. 2020;7:252–60.PubMedPubMedCentral
Metadaten
Titel
Nutritional management of diabetes mellitus during the pandemic of COVID-19: a comprehensive narrative review
verfasst von
Sepideh Mahluji
Mahsa Jalili
Alireza Ostadrahimi
Jamal Hallajzadeh
Vahideh Ebrahimzadeh-Attari
Maryam Saghafi-Asl
Publikationsdatum
05.04.2021
Verlag
Springer International Publishing
Schlagwort
COVID-19
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2021
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-021-00784-5

Weitere Artikel der Ausgabe 1/2021

Journal of Diabetes & Metabolic Disorders 1/2021 Zur Ausgabe

Review article

Identification of the minimum data set to design a mobile-based application on overweight and obesity management for children and adolescents

Research article

Tendon repair by plasma jet treatment

Research article

The association between dietary patterns with severity of coronary artery stenosis, serum leptin-to-adiponectin ratio, and some related risk factors in patients with coronary artery disease

Research article

Hydro alcoholic green tea extract effect on high fat diet treated NMRI mice and 3T3L1 cells

Research article

Momordica charantia silver nanoparticles modulate SOCS/JAK/STAT and P13K/Akt/PTEN signalling pathways in the kidney of streptozotocin-induced diabetic rats

Research article

Mass spectrometry with derivatization method for concurrent measurement of amino acids and acylcarnitines in plasma of diabetic type 2 patients with diabetic nephropathy

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise